FDA Classifies Dräger Neonatal Circuit Recall as Class I

FDA has classified a recall of Dräger’s VentStar Resus Neo — a disposable breathing circuit used to resuscitate and ventilate infants — as Class I, the agency’s most serious category, reserved for defects where continued use could cause serious injury or death. The hose carrying breathing gas to the infant can crack, and a cracked hose can leak or detach outright. Dräger has not yet identified a validated substitute circuit from another manufacturer, which leaves affected units in NICUs and emergency departments without an easy swap-out while the correction plays out.

What actually fails, and when

The VentStar Resus Neo is a single-use, disposable circuit: the tubing that physically carries breathing gas from a ventilator or resuscitation module to a patient small enough to need neonatal-scale equipment — up to 22 pounds. Dräger's own account of the defect, relayed to customers in its recall letter, is a hose that can develop cracks over the course of use or storage. A cracked hose does not fail cleanly; it can leak gas along its length, reducing delivered volume and pressure, or it can detach from its connection point altogether, cutting off ventilation outright. Either failure mode, in a patient who is apneic or otherwise dependent on the circuit for breathing support, can translate quickly into desaturation and hypoxia — which is the clinical logic behind FDA's Class I designation rather than a lower-severity correction.

No substitute circuit, as of the notice

What makes this recall harder to act on than a straightforward product swap is a detail Dräger included in its own September 3 letter: at the time it notified consignees, the company had not identified or validated an alternative breathing circuit from another manufacturer for use with the affected resuscitation module. For a hospital that relies on the VentStar Resus Neo as part of a specific resuscitation setup, that means the near-term response is inspection and vigilance — checking circuits in stock and in active use for visible cracking, and being prepared to respond to a mid-use failure — rather than a same-day substitution. FDA's own early-alert page for the issue, published ahead of the formal Class I classification, carries the same caution to clinical staff: confirm which lots and units are affected, and don't assume an equivalent product is a drop-in replacement without Dräger's own validation.

Why the timeline matters for QA

The gap between Dräger's own notification (early September) and FDA's formal Class I classification (October 1) is routine under the agency's recall process — a firm typically initiates correction and notifies its own customer base before FDA completes its severity review and posts the classification publicly — but it is also exactly the window a hospital's own materials-management and biomed teams need to be watching independently of the federal posting. A facility that waits for the Class I classification to appear on FDA's site before checking its own VentStar Resus Neo inventory against the recall has already lost roughly four weeks relative to Dräger's direct notice. For quality and risk-management teams, the practical lesson repeats one FDA's device-recall program has made before: a manufacturer's own recall correspondence is the operative trigger, not the agency's subsequent classification, which formalizes severity after the fact rather than starting the clock.

Frequently asked questions

What exactly was recalled?

Dräger's VentStar Resus Neo, a single-use disposable breathing circuit, part number MP00310, used with a resuscitation module to deliver breathing gas to infants up to 22 pounds (10 kg) in critical and emergency care. FDA posted the action as a Class I recall, number Z-3252-2026, on October 1, 2026.

What is the defect?

The circuit's hose can develop cracks. If used, a cracked hose can leak gas or detach from its fitting entirely, which can restrict ventilation or delay therapy — a failure mode FDA says can lead to desaturation, hypoxia, or death in an infant who depends on the circuit for breathing support.

Have there been injuries or deaths?

As of August 27, 2026 — the most recent figure in Dräger's recall correspondence — the company had received no reports of serious injury or death tied to the hose-cracking defect.

What should a hospital or clinician do right now?

Dräger notified consignees by an Urgent Medical Device Recall letter emailed on or about September 3, 2026, ahead of FDA's October 1 classification. As of that notice, Dräger had not identified or validated an alternative circuit from another manufacturer for use with the affected resuscitation module, so facilities are being asked to inspect circuits in stock and in use for visible hose cracking rather than switch products outright, pending further instruction from the company.